Increased ceramide synthase 2 and 6 mRNA levels in breast cancer tissues and correlation with sphingosine kinase expression

This publication has 28 references indexed in Scilit:

• Nanoliposomal Short-Chain Ceramide Inhibits Agonist-Dependent Translocation of Neurotensin Receptor 1 to Structured Membrane Microdomains in Breast Cancer Cells
  Molecular Cancer Research, 2009
• Gene expression of ceramide kinase, galactosyl ceramide synthase and ganglioside GD3 synthase is associated with prognosis in breast cancer
  Journal of Cancer Research and Clinical Oncology, 2009
• Deoxycholate promotes survival of breast cancer cells by reducing the level of pro-apoptotic ceramide
  Breast Cancer Research, 2008
• The role of sphingosine kinase 1 in cancer: Oncogene or non-oncogene addiction?
  Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2008
• Roles of Bioactive Sphingolipids in Cancer Biology and Therapeutics
  2008
• Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer
  Breast Cancer Research and Treatment, 2007
• Clinical relevance of ceramide metabolism in the pathogenesis of human head and neck squamous cell carcinoma (HNSCC): Attenuation of C18-ceramide in HNSCC tumors correlates with lymphovascular invasion and nodal metastasis
  Cancer Letters, 2007
• LASS3 (longevity assurance homologue 3) is a mainly testis-specific (dihydro)ceramide synthase with relatively broad substrate specificity
  Biochemical Journal, 2006
• Biologically active sphingolipids in cancer pathogenesis and treatment
  Nature Reviews Cancer, 2004
• Sphingosine-1-phosphate: an enigmatic signalling lipid
  Nature Reviews Molecular Cell Biology, 2003